Does CYPROTERONE Cause Product use in unapproved indication? 51 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Product use in unapproved indication have been filed in association with CYPROTERONE. This represents 6.5% of all adverse event reports for CYPROTERONE.
51
Reports of Product use in unapproved indication with CYPROTERONE
6.5%
of all CYPROTERONE reports
7
Deaths
19
Hospitalizations
How Dangerous Is Product use in unapproved indication From CYPROTERONE?
Of the 51 reports, 7 (13.7%) resulted in death, 19 (37.3%) required hospitalization, and 5 (9.8%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYPROTERONE. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does CYPROTERONE Cause?
Meningioma (378)
Headache (116)
Dementia alzheimer's type (96)
Off label use (91)
Fatigue (66)
Asthenia (53)
Paraesthesia (53)
Dizziness (48)
Visual impairment (48)
Nausea (43)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which CYPROTERONE Alternatives Have Lower Product use in unapproved indication Risk?
CYPROTERONE vs CYPROTERONE\ETHINYL ESTRADIOL
CYPROTERONE vs CYSTEAMINE
CYPROTERONE vs CYTARABINE
CYPROTERONE vs CYTARABINE\DAUNORUBICIN
CYPROTERONE vs DABIGATRAN